APA (7th ed.) Citation

IE, C., I, J., AT, T., J, S., TT, T., S, M., . . . SA, P. (2022). The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study. BMC medicine, 20(1), 378. https://doi.org/10.1186/s12916-022-02587-8

Chicago Style (17th ed.) Citation

IE, Christensen, et al. "The Persistence of Anti-Spike Antibodies Following Two SARS-CoV-2 Vaccine Doses in Patients on Immunosuppressive Therapy Compared to Healthy Controls-a Prospective Cohort Study." BMC Medicine 20, no. 1 (2022): 378. https://doi.org/10.1186/s12916-022-02587-8.

MLA (9th ed.) Citation

IE, Christensen, et al. "The Persistence of Anti-Spike Antibodies Following Two SARS-CoV-2 Vaccine Doses in Patients on Immunosuppressive Therapy Compared to Healthy Controls-a Prospective Cohort Study." BMC Medicine, vol. 20, no. 1, 2022, p. 378, https://doi.org/10.1186/s12916-022-02587-8.